KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Utah

HCR010 • 2026

Concurrent Resolution Directing PEHP Regarding Hormone Replacement Therapy

Concurrent Resolution Directing PEHP Regarding Hormone Replacement Therapy

Labor
Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Rep. Lisonbee, Karianne
Last action
2026-03-25
Official status
Governor Signed
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Concurrent Resolution Directing PEHP Regarding Hormone Replacement Therapy

This resolution directs the Public Employees' Benefit and Insurance Program to provide hormone replacement therapy for menopausal symptoms.

What This Bill Does

  • This resolution directs the Public Employees' Benefit and Insurance Program to provide hormone replacement therapy for menopausal symptoms.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-25 Lieutenant Governor's office for filing

    Governor Signed

  2. 2026-03-17 Clerk of the House

    House/ received enrolled bill from Printing

  3. 2026-03-17 Executive Branch - Governor

    House/ to Governor

  4. 2026-03-12 Clerk of the House

    Enrolled Bill Returned to House or Senate

  5. 2026-03-12 Clerk of the House

    House/ enrolled bill to Printing

  6. 2026-03-10 Legislative Research and General Counsel / Enrolling

    Bill Received from House for Enrolling

  7. 2026-03-10 Legislative Research and General Counsel / Enrolling

    Draft of Enrolled Bill Prepared

  8. 2026-03-07 House Speaker

    House/ received from Senate

  9. 2026-03-07 Legislative Research and General Counsel / Enrolling

    House/ signed by Speaker/ sent for enrolling

  10. 2026-03-06 Senate President

    House/ concurs with Senate amendment

  11. 2026-03-06 House Concurrence Calendar

    House/ placed on Concurrence Calendar

  12. 2026-03-06 Clerk of the House

    House/ received from Senate

  13. 2026-03-06 Senate President

    House/ to Senate

  14. 2026-03-06 Senate Consent Calendar

    Senate/ 3rd reading

  15. 2026-03-06 Clerk of the House

    Senate/ passed 3rd reading

  16. 2026-03-06 Senate President

    Senate/ received from House

  17. 2026-03-06 House Speaker

    Senate/ signed by President/ returned to House

  18. 2026-03-06 House Speaker

    Senate/ to House

  19. 2026-03-06 Clerk of the House

    Senate/ to House with amendments

  20. 2026-03-03 Senate Consent Calendar

    Senate/ 2nd reading

  21. 2026-03-03 Senate Health and Human Services Committee

    Senate/ comm rpt/ amended/ placed on Consent Cal

  22. 2026-03-02 Senate Health and Human Services Committee

    Senate Comm - Amendment Recommendation

  23. 2026-03-02 Senate Health and Human Services Committee

    Senate Comm - Consent Calendar Recommendation

  24. 2026-03-02 Senate Health and Human Services Committee

    Senate Comm - Favorable Recommendation

  25. 2026-02-25 Senate Health and Human Services Committee

    Senate/ to standing committee

  26. 2026-02-24 Senate Rules Committee

    Senate/ 1st reading (Introduced)

  27. 2026-02-23 House 3rd Reading Calendar for House bills

    House/ 3rd reading

  28. 2026-02-23 Senate Secretary

    House/ passed 3rd reading

  29. 2026-02-23 Senate Secretary

    House/ to Senate

  30. 2026-02-23 Waiting for Introduction in the Senate

    Senate/ received from House

  31. 2026-02-17 House Health and Human Services Committee

    House Comm - Favorable Recommendation

  32. 2026-02-17 House 3rd Reading Calendar for House bills

    House/ 2nd reading

  33. 2026-02-17 House Health and Human Services Committee

    House/ committee report favorable

  34. 2026-02-12 House Health and Human Services Committee

    House/ to standing committee

  35. 2026-02-05 House Rules Committee

    House/ received fiscal note from Fiscal Analyst

  36. 2026-02-05 Released

    LFA/ fiscal note publicly available for HCR010

  37. 2026-02-05 Version Sponsor

    LFA/ fiscal note sent to sponsor for HCR010

  38. 2026-02-04 Legislative Research and General Counsel

    Bill Numbered but not Distributed

  39. 2026-02-04 House Rules Committee

    House/ 1st reading (Introduced)

  40. 2026-02-04 Clerk of the House

    House/ received bill from Legislative Research

  41. 2026-02-04 Legislative Fiscal Analyst

    LFA/ bill assigned to staff for fiscal analysis for HCR010

  42. 2026-02-04 Legislative Fiscal Agency

    LFA/ bill sent to agencies for fiscal input for HCR010

  43. 2026-02-04 Legislative Research and General Counsel

    Numbered Bill Publicly Distributed

Official Summary Text

This resolution directs the Public Employees' Benefit and Insurance Program to provide hormone replacement therapy for menopausal symptoms.

Current Bill Text

Read the full stored bill text 
2
0
Concurrent Resolution Directing PEHP Regarding Hormone Replacement Therapy
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Karianne Lisonbee
Senate Sponsor: Heidi Balderree
LONG TITLE
General Description:
This resolution directs the Public Employees' Benefit and Insurance Program to provide
hormone replacement therapy for menopausal symptoms.
Highlighted Provisions:
This resolution:
recognizes that hormone replacement therapy is a safe and effective treatment for
menopausal symptoms; and
directs the Public Employees' Benefit and Insurance Program to provide hormone
replacement therapy for menopausal symptoms.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Be it resolved by the Legislature of the state of Utah, the Governor concurring therein:
WHEREAS, in accordance with Section
49-20-201
, the state participates in the Public
Employees' Benefit and Insurance Program (PEHP);
WHEREAS, menopause is a natural phase of aging when a woman has gone 12 consecutive
months without a menstrual period due to a decline in reproductive hormones;
WHEREAS, menopause can cause a variety of symptoms including irregular periods, hot
flashes, night sweats, vaginal dryness, urinary urgency, difficulty sleeping, emotional changes,
dry skin, worsening premenstrual syndrome, and breast tenderness;
WHEREAS, many menopausal women face barriers accessing effective treatment due to a
range of factors including healthcare provider knowledge gaps, stigma, and lack of readily
available menopause specialists;
WHEREAS, recent studies have shown that hormone replacement therapy (HRT) has a low
risk of adverse events and is a safe treatment for menopausal symptoms;
WHEREAS, FDA-approved HRT treatments can restore estrogen and progesterone, which
naturally decline as women go through menopause;
WHEREAS, in November of 2025, the U.S. Department of Health and Human Services
announced that the U.S. Food and Drug Administration was initiating the removal of broad
"black box" warnings from HRT treatments for menopause:
NOW, THEREFORE, BE IT RESOLVED that the Legislature of the state of Utah, the
Governor concurring therein, directs PEHP for state employees to include in PEHP's drug
formulary HRT treatments to relieve perimenopausal and menopausal symptoms.
BE IT FURTHER RESOLVED that a copy of this resolution be sent to the Public
Employees' Benefit and Insurance Program.
3-12-26 11:03 AM